Inhalis is committed to improve patients’ life with safer and more effective treatment options
Solid science and industry-leading delivery technology are combined with an experienced management team to research and develop new inhaled treatments for Idiopathic Pulmonary Fibrosis and other life-threatening diseases
Inhalis Therapeutics Corso Elvezia, 4 CH-6900 Lugano Switzerland